Recent studies have provided direct evidence that MSCs are recruited in TME by a broad range of soluble factors which are secreted by cancer cells and CSCs, including IL-6 [179], VEGF and bFGF [180], CCL2 [181], SDF-1α [182], and HMGB1 [183]. The gene discussed is CCL2; the disease is cancer.